Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,059,006 papers from all fields of science
Search
Sign In
Create Free Account
MDL 28170
Known as:
MDL-28170
, MDL28170
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
calpain inhibitor III
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Arrested growth of Trypanosoma cruzi by the calpain inhibitor MDL28170 and detection of calpain homologues in epimastigote forms
L. Sangenito
,
V. Ennes-Vidal
,
+4 authors
M. Branquinha
Parasitology
2009
Corpus ID: 11023519
SUMMARY In this paper, we aimed to explore the effects of the calpain inhibitor III (MDL28170) and to detect calpain-like…
Expand
Highly Cited
2008
Highly Cited
2008
Differential regulation of the NMDA receptor by acute and sub‐chronic phencyclidine administration in the developing rat
N. Anastasio
,
K. Johnson
Journal of Neurochemistry
2008
Corpus ID: 35216542
Neurodegeneration induced by the NMDA receptor antagonist, phencyclidine (PCP), has been used to model the pathogenesis of…
Expand
2008
2008
Intraspinal MDL28170 microinjection improves functional and pathological outcome following spinal cord injury.
Chen-Guang Yu
,
Aashish Joshi
,
J. Geddes
Journal of Neurotrauma
2008
Corpus ID: 26217001
Although calpain (calcium-activated cysteine protease) inhibition represents a rational therapeutic target for spinal cord injury…
Expand
2007
2007
Sustained Calpain Inhibition Improves Locomotor Function and Tissue Sparing Following Contusive Spinal Cord Injury
Chen-Guang Yu
,
J. Geddes
Neurochemical Research
2007
Corpus ID: 79287
Following contusive spinal cord injury (SCI), calpain activity is dramatically increased and remains elevated for days to weeks…
Expand
2007
2007
Cardiotrophin‐1 is an essential factor in the natural defense of the liver against apoptosis
J. M. Marqués
,
Idoia Belza
,
B. Holtmann
,
D. Pennica
,
J. Prieto
,
M. Bustos
Hepatology
2007
Corpus ID: 8495043
We previously reported that exogenous cardiotrophin‐1 (CT‐1), a member of the IL‐6 family of cytokines, exerts hepatoprotective…
Expand
2007
2007
Calcium Influx through L-type Channels Generates Protein Kinase M to Induce Burst Firing of Dopamine Cells in the Rat Ventral Tegmental Area*
Yudan Liu
,
Jules J. E. Doré
,
Xihua Chen
Journal of Biological Chemistry
2007
Corpus ID: 20685894
Enhanced activity of the dopaminergic system originating in the ventral tegmental area is implicated in addictive and psychiatric…
Expand
2005
2005
Calpain Inhibitor Inhibits p35-p25-Cdk5 Activation, Decreases Tau Hyperphosphorylation, and Improves Neurological Function after Spinal Cord Hemisection in Rats
Kuo-Sheng Hung
,
Shiuh‐Lin Hwang
,
+5 authors
Cheng-Huang Wang
Journal of Neuropathology and Experimental…
2005
Corpus ID: 14653046
Aberrant calpain activation is a key mediator of neuron death. We examined the cell-permeable calpain inhibitor MDL28170 in the…
Expand
Highly Cited
2004
Highly Cited
2004
Spatiotemporal evidence of apoptosis-mediated ischemic injury in organotypic hippocampal slice cultures
Seongeun Cho
,
Danni Liu
,
+4 authors
A. Wood
Neurochemistry International
2004
Corpus ID: 22455393
2003
2003
Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection.
Shu-xin Zhang
,
Vimala Bondada
,
J. Geddes
Journal of Neurotrauma
2003
Corpus ID: 1997466
Calpains (calcium-activated cysteine proteases) are strongly implicated in the secondary damage that follows contusion injury to…
Expand
2002
2002
Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
P. Kerokoski
,
T. Suuronen
,
A. Salminen
,
H. Soininen
,
T. Pirttilä
Biochemical and Biophysical Research…
2002
Corpus ID: 25215865
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE